September 20, 2011
Chugai Pharmaceutical announced on September 16 that its immunosuppressive agent CellCept (mycophenolate mofetil) has been approved on the same day for an additional pediatric dosage and administration for prophylaxis of organ rejection in renal transplants. The Council on Unapproved Drugs...read more